Company news
Peijia Medical Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2026
November 4, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2026
October 2, 2026
Voluntary announcement
September 25, 2026
Notification Letter and Reply Form to Non-registered Shareholders - Reminder Letter regarding the Arrangement of Electronic Dissemination of Corporate Communications
September 23, 2026
Notification Letter and Reply Form to Registered Shareholders - Reminder Letter regarding the Arrangement of Electronic Dissemination of Corporate Communications
September 23, 2026
Interim Report 2026
September 23, 2026
Peijia Medical Announces 2026 Interim Results, Achieving First-Ever Profit Before Tax on Strong TAVR Growth
August 24, 2026
Peijia Medical Announces 2025 Annual Results
March 26, 2026
DCwire® Micro Guidewire Receives FDA 510(k) Clearance, Marking a Key Milestone in Peijia Medical's Global Expansion
March 18, 2026
Peijia Medical Submits EU MDR CE Mark Registration Application for GeminiOne® TEER System
February 9, 2026
Peijia Medical Receives NMPA Approval for TaurusTrio Transcatheter Aortic Valve System, Pioneering Treatment for Aortic Regurgitation in China
December 12, 2025
Peijia Medical Announces 2025 Interim Results
August 25, 2025
Peijia Medical Announces 2024 Annual Results
March 26, 2025
Peijia Medical Announces 2023 Audited Results Announcement
June 18, 2024
Peijia Medical Reports Audited 2023 Financial Results and Resumes Trading
June 17, 2024
Peijia Medical releases 2023 interim results, sales revenue grows rapidly and gross profit margin increases significantly
September 4, 2023
Peijia Medical Announces 2023 Interim Results
August 31, 2023
Peijia Medical Obtained Exclusive License for JenaValve's Trilogy TAVR System for Treating AR in the Greater China Region
January 19, 2022
Engages Professor Saibal Kar as Exclusive Consultant
September 6, 2021
Voluntary announcement strategic investment in sutra medical
August 26, 2021
With the Second-Generation transcatheter aortic valve replacement system approved for marketing, Peijia Medical leads China into the "Retrievable Era" using TAVR products
June 26, 2021
Peijia Medical and CR PHARMA COMM Sign Memorandum of Strategic Cooperation
June 4, 2021
Peijia Medical: 's TaurusOne® Transcatheter Aortic Valve Replacement System Approved for Commercialization
April 24, 2021
VOLUNTARY ANNOUNCEMENT Update on NMPA Approval for Registration Application of TaurusOne
April 20, 2021
Peijia Medical: Proposed granting of general mandates to issue shares and repurchase shares; proposed re-election of retiring directors; and notice of annual general meeting
April 20, 2021
Voluntary announcement release of partial clinical data of feasibility studies on the highlife sas transcatheter mitral valve replacement system
April 19, 2021
Successfully Commenced Animal Study for its Mitral Valve Edge-to-Edge Repair Product
December 8, 2020
VOLUNTARY ANNOUNCEMENT - Completion of Patient Enrollment for the Clinical Trial of TaurusElite
September 17, 2020